Skip to main content
. 2022 Feb 21;13:842353. doi: 10.3389/fpsyt.2022.842353

Table 3.

Reliable change index for primary outcome measure (S-DAI score).

Participant number Randomization allocation x1 x2 x2 – x1 sx rt SEM st SEdiff RCI Sig.
708 propranolol 24 33 9 7.535 0.88 2.610 6.2 3.037 2.9631 Sig.
786 propranolol 27 27 0 7.535 0.88 2.610 6.2 3.037 0.0000 N/S
860 propranolol 35 28 −7 7.535 0.88 2.610 6.2 3.037 −2.3046 Sig.
942 propranolol 30 23 −7 7.535 0.88 2.610 6.2 3.037 −2.3046 Sig.
945 propranolol 41 43 2 7.535 0.88 2.610 6.2 3.037 0.6585 N/S
947 propranolol 34 28 −6 7.535 0.88 2.610 6.2 3.037 −1.9754 Sig.
949 propranolol 28 28 0 7.535 0.88 2.610 6.2 3.037 0.0000 N/S
950 propranolol 29 15 −14 7.535 0.88 2.610 6.2 3.037 −4.6093 Sig.
953 propranolol 33 20 −13 7.535 0.88 2.610 6.2 3.037 −4.2800 Sig.
954 propranolol 38 39 1 7.535 0.88 2.610 6.2 3.037 0.3292 N/S
957 propranolol 33 20 −13 7.535 0.88 2.610 6.2 3.037 −4,2800 Sig.
959 propranolol 45 45 0 7.535 0.88 2.610 6.2 3.037 0.0000 N/S
961 propranolol 40 38 −2 7.535 0.88 2.610 6.2 3.037 −0.6585 N/S
965 propranolol 41 41 0 7.535 0.88 2.610 6.2 3.037 0.0000 N/S
970 propranolol 16 18 2 7.535 0.88 2.610 6.2 3.037 0.6585 N/S
972 propranolol 22 27 5 7.535 0.88 2.610 6.2 3.037 1.6462 N/S
975 propranolol 33 26 −7 7.535 0.88 2.610 6.2 3.037 −2.3046 Sig.
979 propranolol 34 32 −2 7.535 0.88 2.610 6.2 3.037 −0.6585 N/S
982 propranolol 27 21 −6 7.535 0.88 2.610 6.2 3.037 −1.9754 Sig.
702 placebo 39 27 −12 7.535 0.88 2.610 6.2 3.037 −3.9508 Sig.
709 placebo 32 23 −9 7.535 0.88 2.610 6.2 3.037 −2.9631 Sig.
859 placebo 42 27 −15 7.535 0.88 2.610 6.2 3.037 −4.9385 Sig.
943 placebo 27 35 8 7.535 0.88 2.610 6.2 3.037 2.6339 Sig.
944 placebo 43 43 0 7.535 0.88 2.610 6.2 3.037 0.0000 N/S
948 placebo 20 26 6 7.535 0.88 2.610 6.2 3.037 1.9754 Sig.
952 placebo 26 17 −9 7.535 0.88 2.610 6.2 3.037 −2.9631 Sig.
955 placebo 29 26 −3 7.535 0.88 2.610 6.2 3.037 −0.9877 N/S
956 placebo 30 30 0 7.535 0.88 2.610 6.2 3.037 0.0000 N/S
958 placebo 22 19 −3 7.535 0.88 2.610 6.2 3.037 −0.9877 N/S
960 placebo 31 25 −6 7.535 0.88 2.610 6.2 3.037 −1.9754 Sig.
964 placebo 38 36 −2 7.535 0.88 2.610 6.2 3.037 −0.6585 N/S
966 placebo 35 29 −6 7.535 0.88 2.610 6.2 3.037 −1.9754 Sig.
968 placebo 19 18 −1 7.535 0.88 2.610 6.2 3.037 −0.3292 N/S
973 placebo 28 25 −3 7.535 0.88 2.610 6.2 3.037 −0.9877 N/S
976 placebo 41 27 −14 7.535 0.88 2.610 6.2 3.037 −4.6093 Sig.
980 placebo 35 28 −7 7.535 0.88 2.610 6.2 3.037 −2.3046 Sig.

N/S, Not statistically significant (-1.96 > RCI < 1.96); RCI, Reliable Change Index = (x1 – x2) / Sdiff; rt, Reliability of the test (Cronbach's α); S-DAI, Short version of the Dental Anxiety Inventory with total test scores ranging from 9 to 45 (Aartman, 1998); SEdiff, Standard Error of measurement of the difference = √ (2 · (SEM)2); SEM, Standard Error of the Mean = SX · √ (1 –rt); Sig., Statistically significant (R > 1.96 or RCI < −1.96); st, Standard deviation of the test; sX, Standard deviation of test takers' scores = (sx2 + sx1) / 2; x1, Baseline score; x2, Follow-up score; x2 – x1, Observed difference in score.